Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > HORIBA Medical and CEA-Leti Strengthen Their Partnership to Develop Tomorrow’s Diagnostics at the Point of Care

Abstract:
HORIBA Medical, a subsidiary of Japan-based HORIBA Group, the global leader for measurement and analysis systems, has been designing, manufacturing and marketing high performance analyzers for laboratories and hospitals for over 30 years. This expertise that has made the company one of the world leaders in Hematology and a key player in the Hemostasis and Clinical Chemistry activity.

HORIBA Medical and CEA-Leti Strengthen Their Partnership to Develop Tomorrow’s Diagnostics at the Point of Care

Montpellier and Grenoble, France | Posted on July 21st, 2020

Today, patient care and treatment practices are evolving quickly. HORIBA Medical is designing solutions to anticipate patient-centered needs by developing new POCT (Point of Care Testing) systems.



In parallel, for the past six years HORIBA Medical has been working with one of the most innovative organizations in the field of new technologies, CEA-Leti, the technology research laboratory of CEA Tech, federating their respective skills in a Joint Laboratory called HEMACOUNT.



“We focused on two disruptive technologies: a microfluidic cartridge and a new, lens-free imaging device (LensFree), which will enable development of more compact, easier-to-use POCT-type devices,” says Damien Isebe, who heads up this highly innovative project at HORIBA Medical. “Twelve families of patents have been filed since the start of the project, and the latest one has been the subject of several scientific papers”.



“Flow cytometry is the main analytical technology in hematology, but it requires large and complex hardware systems. Conversely, lens-free imaging combined with a sample prepared as a microfluidic cartridge paves the way to a simple and compact disruptive architecture. This imaging technique provides a wide field of view (≈30mm˛) resulting in a counting statistic (a few thousand cells) in one single acquisition consistent with required hematological performance,” explains Sophie Morales, laboratory head at CEA-Leti.



The latest publications and presentations to date: for LensFree, one publication in the Journal of Biomedical Optics and two oral presentations at ECBO (European Conferences on Biomedical Optics), held in Munich in late June 2019; and for the work on microfluidics, presentation of a scientific poster at µTAS (International Conference on Miniaturized Systems for Chemistry and Life Sciences) in Basel, Switzerland, in October 2019.



Given the success of the partnership and the work that remains to be done, HORIBA Medical is pleased to announce the continuation of this collaboration, which will allow it to draw value from this work in the form of innovative applications, to bring developments to maturity and to design products that will serve care-givers and patients.



Patents: DD17052- FR1663028: “Procedure for counting particles in a sample by lens-free imaging”

####

About Leti
Leti, a technology research institute at CEA, is a global leader in miniaturization technologies enabling smart, energy-efficient and secure solutions for industry. Founded in 1967, CEA-Leti pioneers micro-& nanotechnologies, tailoring differentiating applicative solutions for global companies, SMEs and startups. CEA-Leti tackles critical challenges in healthcare, energy and digital migration. From sensors to data processing and computing solutions, CEA-Leti’s multidisciplinary teams deliver solid expertise, leveraging world-class pre-industrialization facilities. With a staff of more than 1,900, a portfolio of 3,100 patents, 10,000 sq. meters of cleanroom space and a clear IP policy, the institute is based in Grenoble, France, and has offices in Silicon Valley and Tokyo. CEA-Leti has launched 65 startups and is a member of the Carnot Institutes network. Follow us on www.leti-cea.com and @CEA_Leti.

About HORIBA Medical

HORIBA Medical offers an extensive and comprehensive line of hematology, coagulation and clinical chemistry solutions (including reagents) for in vitro diagnostics. The HORIBA Medical brand has earned the trust of a wide customer base through the quality and reliability of its products. Today, over 30,000 laboratories around the world use HORIBA Medical solution (more information at: www.horiba.com).

For more information, please click here

Contacts:
Press Contact HORIBA Medical

Carole Barascud

Public and Media Relations



Tel. +33.4.67.14.15.59



Press Contact CEA-Leti

Agency

Tel. +33 6 74 93 23 47

Copyright © Leti

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Chemistry

Emergence of a new heteronanostructure library May 14th, 2021

News and information

Hanging by a thread: Imaging and probing chains of single atoms: Scientists develop a method to visualize monoatomic chains and measure the strength and conductance of single-atom bonds May 14th, 2021

Nanophotonics enhanced coverslip for phase imaging in biology May 14th, 2021

New technology enables rapid sequencing of entire genomes of plant pathogens May 14th, 2021

Imaging

Hanging by a thread: Imaging and probing chains of single atoms: Scientists develop a method to visualize monoatomic chains and measure the strength and conductance of single-atom bonds May 14th, 2021

Nanophotonics enhanced coverslip for phase imaging in biology May 14th, 2021

Possible Futures

Emergence of a new heteronanostructure library May 14th, 2021

New technology enables rapid sequencing of entire genomes of plant pathogens May 14th, 2021

Harvesting light like nature does:Synthesizing a new class of bio-inspired, light-capturing nanomaterials May 14th, 2021

You're so vein: Scientists discover faster way to manufacture vascular materials May 14th, 2021

Nanomedicine

Implantable 'living pharmacy' could control body's sleep/wake cycles: Project receives DARPA contract worth up to $33 million over 4 1/2 years May 13th, 2021

Tiny, Wireless, Injectable Chips Use Ultrasound to Monitor Body Processes May 12th, 2021

World's first fiber-optic ultrasonic imaging probe for future nanoscale disease diagnostics April 30th, 2021

Arrowhead Announces Improvement in Fibrosis after ARO-AAT Treatment in Patients with Alpha-1 Liver Disease April 28th, 2021

Discoveries

Emergence of a new heteronanostructure library May 14th, 2021

Hanging by a thread: Imaging and probing chains of single atoms: Scientists develop a method to visualize monoatomic chains and measure the strength and conductance of single-atom bonds May 14th, 2021

Nanophotonics enhanced coverslip for phase imaging in biology May 14th, 2021

You're so vein: Scientists discover faster way to manufacture vascular materials May 14th, 2021

Announcements

Emergence of a new heteronanostructure library May 14th, 2021

Nanophotonics enhanced coverslip for phase imaging in biology May 14th, 2021

New technology enables rapid sequencing of entire genomes of plant pathogens May 14th, 2021

Harvesting light like nature does:Synthesizing a new class of bio-inspired, light-capturing nanomaterials May 14th, 2021

Patents/IP/Tech Transfer/Licensing

Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020

A new study published on the cover of Science could bolster the development of batteries, fuel cells, 3D printing technologies and more May 1st, 2020

New green technology from UMass Amherst generates electricity 'out of thin air' Renewable device could help mitigate climate change, power medical devices February 17th, 2020

The Wave of the Future: Researchers achieve first successful generation and detection of pure spin currents in antiferromagnetic materials January 29th, 2020

Nanobiotechnology

Implantable 'living pharmacy' could control body's sleep/wake cycles: Project receives DARPA contract worth up to $33 million over 4 1/2 years May 13th, 2021

Tiny, Wireless, Injectable Chips Use Ultrasound to Monitor Body Processes May 12th, 2021

Arrowhead Announces Improvement in Fibrosis after ARO-AAT Treatment in Patients with Alpha-1 Liver Disease April 28th, 2021

Synthetic gelatin-like material mimics lobster underbelly’s stretch and strength: The membrane’s structure could provide a blueprint for robust artificial tissues April 23rd, 2021

Research partnerships

Nanophotonics enhanced coverslip for phase imaging in biology May 14th, 2021

Implantable 'living pharmacy' could control body's sleep/wake cycles: Project receives DARPA contract worth up to $33 million over 4 1/2 years May 13th, 2021

Graphene key for novel hardware security May 10th, 2021

Silver ions hurry up, then wait as they disperse: Rice chemists show ions’ staged release from gold-silver nanoparticles could be useful property April 23rd, 2021

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project